Unknown

Dataset Information

A two-SNP IL-6 promoter haplotype is associated with increased lung cancer risk.


ABSTRACT:

Background

Aberrant expression of interleukin-6 (IL-6) may play an important role in lung carcinogenesis. Whether IL-6 promoter haplotypes are associated with lung cancer risk and their functions have not yet been studied. We tested the hypothesis that single-nucleotide polymorphism (SNP) and/or haplotypes of IL-6 promoter are associated with risk of lung cancer.

Methods

Two functional IL-6 promoter SNPs (-6331T>C and -572C>G) were genotyped in the discovery group including 622 patients and 614 controls, and the results were replicated in an independent validation group including 615 patients and 638 controls. Luciferase reporter gene assays were conducted to examine the function of IL-6 promoter haplotypes.

Results

None of the functional IL-6 promoter SNPs were assoc

SUBMITTER: Chen J 

PROVIDER: S-EPMC4535449 | biostudies-literature | 2013 Feb

REPOSITORIES: biostudies-literature